PET imaging of cerebral astrocytoma with 13N-ammonia

Journal of Neuro-Oncology

Volumn 78, Issue 2, 2006, Pages 145-151

  Xiangsong, Zhang ^a,b   Changhong, Liang ^b   Weian, Chen ^a   Dong, Zhou ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Ammonia; Astrocytoma; Nitrogen radioisotopes; PET

Indexed keywords

AMMONIA N 13; GADOLINIUM PENTETATE MEGLUMINE; AMMONIA; DIAGNOSTIC AGENT; NITROGEN; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN INFARCTION; BRAIN NECROSIS; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOTOMY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION NECROSIS; RECURRENT CANCER; BRAIN TUMOR; CANCER STAGING; CLINICAL TRIAL; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AMMONIA; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NITROGEN ISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 33748145174     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9069-x     Document Type: Article

References (22)

1. Ricci PE, (1999). Imaging of adult brain tumors Neuroimag Clin N Am 9:651-669
2. Chung JK, Kim YK, Kim SK, et al, (2002). Usefulness of 11 C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18 F-FDG PET Eur J Nucl Med 29:176-182
3. Roelcke U, Radu EW, von Ammon K, et al, (1995) Alteration of blood-brain barrier in human brain tumors: Comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET J Neurol Sci.132: 20-27
4. Ogawa T, Shishido F, Kanno I, et al, (1993). Cerebral glioma: Evaluation with methionine PET Radiology 186: 45-53
5. Ohtani T, Kurihara H, Ishiuch S, et al, (2001). Brain tumour imaging with 11 C-choline: Comparison with FDG PET and gadolinium-enhanced MR imaging Eur J Nucl Med 28: 1664-1679
6. Kleihues P, Cavenee W, (2000). Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer; Lyon, pp.107-109
7. Hoop B, Hnatowich DJ, Brownell GL, et al, (1976). Techniques for positron scintigraphy of the brain J Nucl Med 17: 473-479
8. Schelstraete K, Simons M, Deman J, et al, (1982) Uptake of 13 N-ammonia by human tumours as studied by positron emission tomography Br J Radiol 55: 797-804
9. Benard F, Romsa J, Hustinx R, (2003). Imaging gliomas with positron emission tomography and single-photon emission computed tomography Semin Nucl Med 33: 148-162
10. Schelbert HR, Phelps ME, Huang SC, et al, (1981). N-13 ammonia as an indicator of myocardial blood flow Circulation 63: 1259-1272
11. Phelps ME, Hoffman EJ, Coleman RE, et al, (1976). Tomographic images of blood pool and perfusion in brain and heart J Nucl Med 17: 603-612
12. Phelps ME, Huang SC, Hoffman EJ, et al, (1981). Cerebral extraction of N-13 ammonia: Its dependence on cerebral blood flow and capillary permeability-surface area product Stroke 12: 607-619
13. Bergmann SR, Hack S, Tewson T, et al, (1980). The dependence of accumulation of 13 NH 3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion Circulation 61: 34-43
14. Cooper AJL, McDonald JM, Gelbard AS, et al, (1979). The metabolic fate of 13 N-labeled ammonia in rat brain J Biol Chem 254: 4982-4992
15. Pilkington GJ, Lantos PL, (1982). The role of glutamine synthetase in the diagnosis of cerebral tumours Neuropathol Appl Neurobiol 8: 227-236
16. Akimoto J. (1993). Immunohistochemical study of glutamine synthetase expression in normal human brain and intracranial tumors No To Shinkei 45: 362-368
17. McCormick D, McQuaid S, McCusker, et al, (1990). A study of glutamine synthetase in normal human brain and intracranial tumours Neuropathol Appl Neurobiol 16: 205-211
18. Mineura K, Sasajima T, Kowada M, et al, (1994). Perfusion and metabolism in predicting the survival of patients with cerebral gliomas Cancer 73: 2386-2394
19. Pruel MC, Caramanos Z, Collins DL, et al, (1996). Accurate noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy Nature Med 2: 323-325
20. Somorjai RL, Dolenko B, Nikulin AK, et al, (1996). Classification of H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis classification accuracy J Magn Reson Imaging 6: 437-444
21. Taylor JS, Langston JW, Peddick WE, et al, (1996). Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis Int J Radiat Oncol Biol Phys 36: 1251-1261
22. Negendank WG, Sauter R, Brown TR, et al, (1996). Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study J Neurosurg 84: 449-458